TabsDetailsEvent InformationDate: Saturday, August 24, 2019Event Type: ConferenceDescription: The 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) was held August 24-28, 2019, in Philadelphia, PA. More information on the conference can be found here.A variety of Sentinel-related work was featured, including presentations, posters, and more. These materials have been made available below. Read More Event Materials: Podium/Oral PresentationsUtility of Prenatal Tests and Fertility Coding to Estimate Pregnancy Start in the Sentinel Distributed DatabaseCharacteristics of Febuxostat and Allopurinol Initiators and Utilization Patterns in Real-World SettingsA General Propensity Score for Signal Detection using Tree-Based Scan StatisticsAnalysis of SGLT2 Inhibitor Use in Patients with Type-1 Diabetes Mellitus and Rates of Diabetic Ketoacidosis13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Kawasaki DiseasePostersDolutegravir Use Among Women of Child-Bearing Potential and During Early Pregnancy Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illnesses in Young Children Phosphodiesterase-5 Inhibitor Use Among Pregnant Women and Women of Child-bearing Age in the United StatesConfounding Variable Capture in Large Healthcare Administrative Claims Databases: A Trend Analysis in Sentinel Data SystemCharacteristics of NOAC Users Aged Less Than 65 Years in the Sentinel System Evidence of Residual Confounding in Healthcare Database Studies of Oseltamivir and Influenza ComplicationsCharacteristics and Treatment Status of Those with Influenza-Like Illness: Implications for Effectiveness Studies and SurveillanceUtilization of Prescription Anti-Obesity Drugs in the U.S. Food and Drug Administration's (FDA) Sentinel System, 2008-2017Duration of Follow-up of Chronic Condition Cohorts in the Sentinel System Identification of Ordinal Endpoints Indicating Influenza Complications: A Feasibility Analysis Relevant to the Study of Medical CountermeasuresComplementary Use of US FDA's Adverse Event Reporting System and Sentinel Distributed Database to Characterize Direct Oral Anticoagulants Associated Cutaneous Small Vessel Vasculitis Biosimilar Use in the United States: A Sentinel Analysis of Filgrastim and InfliximabExposure to N-nitrosodimethylamine (NDMA)/N-nitrosodiethylamine (NDEA)-contaminated Angiotensin-II Receptor Blockers Products in the United StatesSymposiaExperience from US FDA Sentinel Initiative StudiesThinking Globally While Acting Locally: Developing Time-on-Treatment Data In International SettingsAdditional InformationInformationHost: International Society for PharmacoepidemiologyRelated Assessment(s): Abstracts of the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA, August 24‐28, 2019
